Reed E Coast, DPM
Podiatry · San Rafael
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 10 years
- California School of Podiatric Medicine, 2016
Offices
1 location · Bay Area Foot Care Inc · 127 clinicians in this group
Hospitals listed: California Pacific Medical Center - Mission Bernal · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Coast’s office at (415) 472-5575 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$252,936
Medicare paid this office $252,936 for 698 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 373 | $76,466 | $82 |
| Removal of fingernails or toenails, 6 or more nails | 258 | $32,271 | $41 |
| Return visit (30+ min) | 101 | $22,168 | $120 |
| Test or measurement for functional capacity, each 15 minutes | 367 | $21,447 | $28 |
| New patient visit (30+ min) | 118 | $10,770 | $91 |
See all 14 services
| Short return visit (20+ min) | 373 | $76,466 | $82 |
| Removal of fingernails or toenails, 6 or more nails | 258 | $32,271 | $41 |
| Return visit (30+ min) | 101 | $22,168 | $120 |
| Test or measurement for functional capacity, each 15 minutes | 367 | $21,447 | $28 |
| New patient visit (30+ min) | 118 | $10,770 | $91 |
| New patient visit (45+ min) | 63 | $9,428 | $150 |
| Removal of noncancer thickened skin growth, 2-4 growths | 48 | $9,106 | $81 |
| Removal of skin and tissue, 20.0 sq cm or less | 24 | $7,422 | $135 |
| Removal of noncancer thickened skin growth, 1 growth | 45 | $7,307 | $69 |
| X-ray of foot, minimum of 3 views | 85 | $4,508 | $35 |
| Permanent removal fingernail or toenail | 13 | $2,183 | $146 |
| Aspiration and/or injection of fluid from small joint | 11 | $591 | $54 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $38 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 31 | $7 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of nail tissue | 791 | More than 89% of doctors who do this |
| Removal of tissue | 50 | More than 78% of doctors who do this |
| Removal or shaving of skin growth | 269 | More than 92% of doctors who do this |
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of fingernails or toenails, 6 or more nails | 215 | 595 | 761 | 813 | 891 | 786 |
| Removal of noncancer thickened skin growth, 2-4 growths | 51 | 129 | 121 | 128 | 132 | 113 |
| Removal of noncancer thickened skin growth, 1 growth | 60 | 85 | 109 | 105 | 103 | 106 |
| Removal of skin and tissue, 20.0 sq cm or less | – | 89 | 132 | 88 | 117 | 55 |
| Permanent removal fingernail or toenail | – | – | 14 | 22 | – | 15 |
| Removal of fingernails or toenails, 1-5 nails | 29 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
698 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 23% · Women 57% · Also on Medicaid 30% · Health risk score 1.41. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 70% · Diabetes 36% · Chronic kidney disease 28% · Coronary heart disease 26% · Depression 22% · Atrial fibrillation 21% · Cancer 19% · Heart failure 18% · COPD 14% · Stroke 11% · Dementia 10%.
The office billed $951,565, Medicare allowed $345,993 and paid $252,936; for 3,629 services of 62 kinds; $30,997 of it was for drugs given in the office and $221,939 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 698 | 3,629 | 77 | 1.41 | $951,565 | $252,936 |
| 2023 | 752 | 2,991 | 77 | 1.55 | $886,218 | $213,051 |
| 2022 | 759 | 2,603 | 77 | 1.46 | $655,240 | $176,918 |
| 2021 | 685 | 2,701 | 77 | 1.45 | $539,420 | $186,827 |
| 2020 | 663 | 2,053 | 77 | 1.46 | $403,201 | $135,201 |
| 2019 | 328 | 754 | 78 | 1.40 | $137,426 | $48,914 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 420 | $72,470 | $77 |
| Removal of fingernails or toenails, 6 or more nails | 294 | $35,258 | $40 |
| Return visit (30+ min) | 76 | $18,387 | $112 |
| Removal of skin and tissue, 20.0 sq cm or less | 27 | $14,995 | $128 |
| New patient visit (30+ min) | 140 | $12,966 | $93 |
| Removal of noncancer thickened skin growth, 2-4 growths | 58 | $10,476 | $79 |
| Removal of noncancer thickened skin growth, 1 growth | 54 | $6,989 | $68 |
| New patient visit (45+ min) | 39 | $5,104 | $131 |
| X-ray of foot, minimum of 3 views | 76 | $3,434 | $32 |
| Test or measurement for functional capacity, each 15 minutes | 64 | $3,293 | $29 |
| Aspiration and/or injection of fluid from large joint | 12 | $732 | $46 |
2022: 11 services
| Short return visit (20+ min) | 380 | $61,361 | $73 |
| Removal of fingernails or toenails, 6 or more nails | 275 | $31,256 | $38 |
| New patient visit (30+ min) | 163 | $14,068 | $86 |
| Return visit (30+ min) | 70 | $13,941 | $110 |
| Removal of skin and tissue, 20.0 sq cm or less | 27 | $10,832 | $123 |
| Removal of noncancer thickened skin growth, 2-4 growths | 63 | $10,076 | $79 |
| Removal of noncancer thickened skin growth, 1 growth | 52 | $7,076 | $67 |
| New patient visit (45+ min) | 26 | $3,974 | $153 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,327 | $115 |
| Permanent removal fingernail or toenail | 20 | $3,138 | $143 |
| X-ray of foot, minimum of 3 views | 57 | $2,327 | $32 |
2021: 14 services
| Short return visit (20+ min) | 380 | $71,711 | $78 |
| Removal of fingernails or toenails, 6 or more nails | 230 | $29,600 | $39 |
| New patient visit (30+ min) | 204 | $19,021 | $93 |
| Removal of skin and tissue, 20.0 sq cm or less | 34 | $15,986 | $121 |
| Removal of noncancer thickened skin growth, 2-4 growths | 49 | $9,172 | $76 |
| Removal of noncancer thickened skin growth, 1 growth | 62 | $6,659 | $61 |
| X-ray of foot, minimum of 3 views | 50 | $2,465 | $33 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,302 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,183 | $64 |
| Permanent removal fingernail or toenail | 12 | $2,104 | $150 |
| Return visit (30+ min) | 16 | $1,468 | $86 |
| Strapping, unna boot | 11 | $652 | $47 |
| X-ray of ankle, minimum of 3 views | 14 | $569 | $33 |
| X-ray of foot, 2 views | 13 | $437 | $27 |
2020: 10 services
| Short return visit (20+ min) | 313 | $43,471 | $66 |
| Removal of fingernails or toenails, 6 or more nails | 246 | $24,406 | $41 |
| New patient visit (30+ min) | 256 | $22,636 | $88 |
| Removal of skin and tissue, 20.0 sq cm or less | 20 | $10,447 | $117 |
| Removal of noncancer thickened skin growth, 2-4 growths | 70 | $8,793 | $68 |
| Removal of noncancer thickened skin growth, 1 growth | 59 | $4,992 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,982 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,704 | $66 |
| X-ray of foot, minimum of 3 views | 44 | $1,325 | $28 |
| X-ray of foot, 2 views | 12 | $365 | $28 |
2019: 8 services
| New patient visit (30+ min) | 198 | $19,412 | $98 |
| Removal of fingernails or toenails, 6 or more nails | 157 | $9,232 | $43 |
| Short return visit (20+ min) | 73 | $6,673 | $69 |
| Removal of noncancer thickened skin growth, 1 growth | 48 | $3,335 | $56 |
| Removal of noncancer thickened skin growth, 2-4 growths | 42 | $3,332 | $65 |
| Removal of fingernails or toenails, 1-5 nails | 25 | $928 | $32 |
| Trimming of dystrophic nails, any number | 22 | $474 | $18 |
| X-ray of foot, minimum of 3 views | 15 | $460 | $29 |
Medicaid work
$21,143 in 2024
Medicaid paid $21,143 for 401 billed services this clinician did in 2024, up to 37 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 293 | $17,688 |
| Debridement of nail(s) by any method(s); 6 or more | 108 | $3,455 |
| 2024 | 401 | 2 | 37 | $21,143 |
| 2023 | 221 | 2 | 24 | $10,077 |
| 2022 | 113 | 2 | 21 | $2,111 |
| 2021 | 424 | 2 | 23 | $7,162 |
| 2020 | 325 | 3 | 20 | $4,128 |
| 2019 | 33 | 2 | 17 | $0 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 133 | $6,552 |
| Debridement of nail(s) by any method(s); 6 or more | 88 | $3,524 |
2022
| Short return visit (20+ min) | 67 | $1,891 |
| Debridement of nail(s) by any method(s); 6 or more | 46 | $219 |
2021
| Short return visit (20+ min) | 207 | $4,917 |
| Debridement of nail(s) by any method(s); 6 or more | 217 | $2,246 |
2020
| Short return visit (20+ min) | 129 | $2,709 |
| Debridement of nail(s) by any method(s); 6 or more | 176 | $1,194 |
| New patient visit (30+ min) | 20 | $225 |
2019
| Debridement of nail(s) by any method(s); 6 or more | 17 | $0 |
| New patient visit (30+ min) | 16 | $0 |
Drugs they prescribed that Part D paid
$16,015
Pharmacies billed $16,015 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (37 of 534) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
526 generic and fewer than 11 brand-name prescriptions · $16,015 in drug cost · 45 antibiotic prescriptions to 29 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 94 | $2,738 | $29 |
| Ciclopirox | 46 | $1,253 | $27 |
| Gabapentin | 97 | $1,000 | $10 |
| Doxycycline Hyclate | 21 | $352 | $17 |
| Terbinafine | 19 | $279 | $15 |
See all 9 drugs
| Ketoconazole | 94 | $2,738 | $29 |
| Ciclopirox | 46 | $1,253 | $27 |
| Gabapentin | 97 | $1,000 | $10 |
| Doxycycline Hyclate | 21 | $352 | $17 |
| Terbinafine | 19 | $279 | $15 |
| Clotrimazole-Betamethasone | 13 | $254 | $20 |
| Pregabalin | 15 | $252 | $17 |
| Hydrocodone-Acetaminophen | 30 | $248 | $8 |
| Meloxicam | 104 | $238 | $2 |
Year by year
| 2024 | 534 | 240 | 7% (37) | None | $16,015 |
| 2023 | 563 | 207 | 6% (34) | None | $21,023 |
| 2022 | 468 | 197 | 9% (41) | None | $16,590 |
| 2021 | 404 | 207 | 12% (50) | None | $9,120 |
| 2020 | 332 | 167 | 7% (23) | 4% | $11,140 |
| 2019 | 64 | 45 | None | None | $1,757 |
| 2017 | 24 | None | 0% (0) | None | $198 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Ketoconazole | 95 | $4,538 | $48 |
| Ciclopirox | 48 | $1,656 | $34 |
| Gabapentin | 122 | $1,299 | $11 |
| Diclofenac | 28 | $921 | $33 |
| Clotrimazole-Betamethasone | 11 | $477 | $43 |
| Hydrocodone-Acetaminophen | 28 | $436 | $16 |
| Clotrimazole | 17 | $401 | $24 |
| Terbinafine | 24 | $239 | $10 |
| Meloxicam | 58 | $231 | $4 |
| Amoxicillin-Clavulanate Potass | 20 | $224 | $11 |
| Ibuprofen | 12 | $76 | $6 |
2022: 10 drugs
| Ketoconazole | 70 | $3,636 | $52 |
| Lidocaine | 21 | $3,326 | $158 |
| Ciclopirox | 80 | $2,841 | $36 |
| Econazole Nitrate | 12 | $1,936 | $161 |
| Gabapentin | 65 | $756 | $12 |
| Hydrocodone-Acetaminophen | 34 | $407 | $12 |
| Diclofenac | 13 | $349 | $27 |
| Terbinafine | 12 | $342 | $29 |
| Clotrimazole-Betamethasone | 17 | $294 | $17 |
| Meloxicam | 60 | $219 | $4 |
2021: 11 drugs
| Ketoconazole | 53 | $3,038 | $57 |
| Ciclopirox | 42 | $1,099 | $26 |
| Econazole Nitrate | 27 | $987 | $37 |
| Lidocaine | 18 | $667 | $37 |
| Clotrimazole-Betamethasone | 17 | $547 | $32 |
| Hydrocodone-Acetaminophen | 41 | $500 | $12 |
| Diclofenac | 15 | $293 | $20 |
| Meloxicam | 60 | $207 | $3 |
| Gabapentin | 29 | $174 | $6 |
| Terbinafine | 11 | $146 | $13 |
| Cephalexin | 13 | $71 | $5 |
2020: 10 drugs
| Diclofenac | 79 | $1,981 | $25 |
| Econazole Nitrate | 22 | $1,307 | $59 |
| Lidocaine | 17 | $963 | $57 |
| Ciclopirox | 34 | $827 | $24 |
| Clotrimazole | 18 | $362 | $20 |
| Clotrimazole-Betamethasone | 14 | $297 | $21 |
| Hydrocodone-Acetaminophen | 15 | $228 | $15 |
| Meloxicam | 31 | $118 | $4 |
| Cephalexin | 13 | $60 | $5 |
| Gabapentin | 13 | $55 | $4 |
2019: 2 drugs
| Diclofenac | 13 | $350 | $27 |
| Meloxicam | 18 | $50 | $3 |
2017: 1 drug
| Pantoprazole | 11 | $62 | $6 |
Money from drug and device companies
$786 in 2025
| 2025 | 8 | 16 | None | $786 |
| 2024 | 7 | 12 | None | $1,028 |
| 2023 | 8 | 12 | None | $1,346 |
| 2022 | 5 | 11 | None | $578 |
| 2021 | 4 | 8 | None | $361 |
| 2020 | 9 | 22 | None | $881 |
| 2019 | 4 | 14 | None | $591 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $165 | 3 payments
|
| Stryker | Flexband | $154 | 1 payment
|
| Treace Medical Concepts | Lapiplasty System 1 | $134 | 3 payments
|
| Kerecis | Kerecis Surgiclose | $119 | 4 payments
|
| Paragon 28 | Phantom Fibula Nail | $118 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $42 | 2 payments
|
See all 16 published payments
| Curonix | Meals · 2025-12-03 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $24 |
| Globus Medical | Meals · 2025-11-03 | Senza | $28 |
| Smith+Nephew | Meals · 2025-10-28 | Collagenase Santyl | $26 |
| Kerecis | Meals · 2025-10-02 | Kerecis Surgiclose | $10 |
| Paratek Pharmaceuticals | Meals · 2025-08-27 | Nuzyra | $22 |
| Kerecis | Meals · 2025-07-24 | Kerecis Surgiclose | $4 |
| Paragon 28 | Meals · 2025-06-28 | Phantom Fibula Nail | $118 |
| Kerecis | Meals · 2025-06-28 | Kerecis Surgiclose | $98 |
| Treace Medical Concepts | Meals · 2025-06-25 | Lapiplasty System 1 | $17 |
| Kerecis | Meals · 2025-06-10 | Kerecis Surgiclose | $7 |
| Stryker | Meals · 2025-04-17 | Flexband | $154 |
| Treace Medical Concepts | Meals · 2025-02-25 | None | $56 |
| Paratek Pharmaceuticals | Meals · 2025-02-10 | Nuzyra | $19 |
| Curonix | Meals · 2025-01-14 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $31 |
| Treace Medical Concepts | Meals · 2025-01-14 | None | $60 |
| Curonix | Meals · 2025-01-07 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $111 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,028
| Alafair Biosciences | Versawrap | $358 | 3 payments
|
| Orthofix Medical | Accelstim | $191 | 3 payments
|
| Exactech | Vantage | $171 | 1 payment
|
| Stryker | Prostep Mica | $128 | 1 payment
|
| Kerecis | Kerecis Omega3 Surgiclose | $92 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $59 | 2 payments
|
| Fusion Orthopedics USA | None | $30 | 1 payment
|
2023: $1,346
| Stryker | Citrefix | $620 | 3 payments
|
| Treace Medical Concepts | Lapiplasty System | $186 | 2 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $151 | 1 payment
|
| Smith+Nephew | Pico | $146 | 1 payment
|
| Organogenesis | Puraply | $106 | 1 payment
|
| Evolution Surgical | None | $68 | 1 payment
|
| Paragon 28 | Phantom Metatarsal Shortening | $44 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $26 | 1 payment
|
2022: $578
| Paragon 28 | Paratrooper | $181 | 3 payments
|
| Nevro | Omnia | $161 | 2 payments
|
| Smith+Nephew | Collagenase Santyl | $116 | 3 payments
|
| Treace Medical Concepts | Lapiplasty System | $73 | 1 payment
|
| Orthofix Medical | Physio-Stim | $46 | 2 payments
|
2021: $361
| Stryker | Anchorage | $123 | 2 payments
|
| Paragon 28 | Gorilla Plating System | $100 | 1 payment
|
| Smith+Nephew | Grafix Pl | $91 | 3 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $47 | 2 payments
|
2020: $881
| Smith+Nephew | Grafix Pl | $591 | 13 payments
|
| Stryker | Anchorage | $127 | 2 payments
|
| Radius Health | Tymlos | $34 | 1 payment
|
| Evolution Surgical | None | $30 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $22 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $22 | 1 payment
|
| DePuy Synthes Sales | Vivigen | $16 | 1 payment
|
| Corcept Therapeutics | Korlym | $16 | 1 payment
|
2019: $591
| Smith+Nephew | Stravix | $435 | 10 payments
|
| Paragon 28 | None | $100 | 1 payment
|
| Wright Medical Technology | Crosscheck | $42 | 2 payments
|
| Bioventus | Exogen | $14 | 1 payment
|
Checkups this office reported
11 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 84.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 64%That's more than half. | 44 |
| Checked for fall riskOlder patients screened for fall risk | 25%That's less than half. | 833 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 14% | 106 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 76%That's most of the people this applied to. Worse on this measure. | 202 |
| Medications listed in the chartVisits where the current medication list was documented | 78%That's most of the people this applied to. | 3,653 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 59%That's more than half. | 1,060 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 222 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 857 |
See the other 3 measures
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 4% | 3,558 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 81%That's most of the people this applied to. | 228 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 53%That's more than half. | 1,732 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of fall screening and assessment programs
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from e-prescribing
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1255795050
- Licence
- CA E5597, CA EL6799
- Trained
- California School of Podiatric Medicine, 2016 · 10 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X); Student in a training program (390200000X)
- Mailing address
- 2299 Post St Ste 205, San Francisco, CA, 94115
- NPI first listed
- 2016-04-07
- NPI last updated
- 2020-11-16
- NPI record certified
- 2020-11-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1800 Sullivan Ave Rm 401, Daly City, CA, 94015 · 450 Stanyan St, San Francisco, CA, 94117